Demegestone
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
Synonyms | R-2453, RU-2453; 17α-Methyl-19-norpregna-4,9-diene-3,20-dione |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ECHA InfoCard | 100.030.278 |
Chemical and physical data | |
Formula | C21H28O2 |
Molar mass | 312.446 g/mol |
3D model (JSmol) | |
| |
|
Demegestone (INN) (brand name Lutionex), also known as 17α-methyl-Δ9-19-norprogesterone or 17α-methyl-19-norpregna-4,9-diene-3,20-dione,[1] is a steroidal progestin of the 19-norprogesterone group which was introduced by Roussel in France in 1974.[1][2] Like other 19-norprogesterone derivatives, it has relatively high affinity for the progesterone receptor and shows little or no activity at other steroid hormone receptors.[3]
See also
References
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 356–. ISBN 978-1-4757-2085-3.
- ↑ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 1215–. ISBN 978-0-8155-1856-3.
- ↑ Ian Milsom (2006). Contraception and Family Planning. Elsevier Health Sciences. pp. 102–. ISBN 0-444-51828-2.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.